Date of management change: December 15, 2016
Kirkland, AB-based Mavupharma Appointed Michael Gallatin as Founder and Chief Executive Officer
Mavupharma is developing non-nucleotide, conditional modulators of the STING pathway to treat cancer and infectious disease.
Michael Gallatin is Founder and Chief Executive Officer at Mavupharma. Previously, Michael held various senior HR leadership roles in the industry.
News
Short ProfileName: Michael Gallatin
Title: Founder and Chief Executive Officer
Company: Mavupharma
Industry: Biotechnology
Current Contact InfoEmail: *********@mavupharma.com
Phone:
To get full contact details, please sign in or
Other IT executives who recently changed jobs as well: Macias Jason, Mary Reavis, Mohan Patrick, Jensen Steve, Biffle Melody, Killingsworth Michael, Weslock Kathleen, Martin Suzanne, Hickman Mark, Franzen Roberta, Fuller Jenny
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.
